Argenx
ARGX
#470
Rank
โ‚น4.757 T
Marketcap
โ‚น76,876
Share price
-0.34%
Change (1 day)
37.85%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น807.53. In 2024 the company made an earnings per share (EPS) of โ‚น1,267 an increase over its 2023 EPS that were of -โ‚น469.77.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-38.71%
2024โ‚น1,267-369.77%
2023-โ‚น469.77-60.46%
2022-โ‚น1,18863.33%
2021-โ‚น727.42-40.37%
2020-โ‚น1,220183.47%
2019-โ‚น430.36123.09%
2018-โ‚น192.9154.93%
2017-โ‚น124.5114.07%
2016-โ‚น109.1513.05%
2015-โ‚น96.55-36.34%
2014-โ‚น151.67209.04%
2013-โ‚น49.08-33.99%
2012-โ‚น74.35185.59%
2011-โ‚น26.03